Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Busch

Showing results (191-200 of 844) with videos related to

Pageof 85
Sort By:
Transfusion|October 19, 2002
International application of the incidence rate/window period modelSimone A Glynn, Steven H Kleinman, David J Wright, et al.
Transfusion|October 24, 2020
Estimating the incidence of HIV infection in repeat blood donors with low average donation frequencyDonald J Brambilla, Michael P Busch, Simone A Glynn, et al.
Vox Sanguinis|March 24, 2000
Evaluation of the safety of Rh immunoglobulin by monitoring viral markers among Rh-negative female blood donorsK K Watanabe, M P Busch, G B Schreiber, et al.
Transfusion|February 1, 1994
Declining efficacy of AIDS case list cross-referencing in human immunodeficiency virus look-back: 1981 through 1992S M Samson, R K Edmiston, M P Busch, et al.
Plos One|July 7, 2012
Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell countsÉlcio Leal, Jorge Casseb, Michael Hendry, et al.
Transfusion Medicine Reviews|October 1, 1990
Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collectionB D Rawal, R E Davis, M P Busch, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study GroupE A Operskalski, M P Busch, J W Mosley, et al.
The Journal of Laboratory and Clinical Medicine|September 14, 2000
Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivityE Carrier, E Gilpin, T H Lee, et al.
Hepatology (Baltimore, Md.)|February 1, 1993
Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donorsJ M Romeo, P P Ulrich, M P Busch, et al.
Transfusion|May 22, 2003
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donationsB R Jackson, M P Busch, S L Stramer, et al.
Pageof 85

Showing results (191-200 of 844) with videos related to

Sort By:
Pageof 85
Transfusion|October 19, 2002
International application of the incidence rate/window period modelSimone A Glynn, Steven H Kleinman, David J Wright, et al.
Transfusion|October 24, 2020
Estimating the incidence of HIV infection in repeat blood donors with low average donation frequencyDonald J Brambilla, Michael P Busch, Simone A Glynn, et al.
Vox Sanguinis|March 24, 2000
Evaluation of the safety of Rh immunoglobulin by monitoring viral markers among Rh-negative female blood donorsK K Watanabe, M P Busch, G B Schreiber, et al.
Transfusion|February 1, 1994
Declining efficacy of AIDS case list cross-referencing in human immunodeficiency virus look-back: 1981 through 1992S M Samson, R K Edmiston, M P Busch, et al.
Plos One|July 7, 2012
Relaxation of adaptive evolution during the HIV-1 infection owing to reduction of CD4+ T cell countsÉlcio Leal, Jorge Casseb, Michael Hendry, et al.
Transfusion Medicine Reviews|October 1, 1990
Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collectionB D Rawal, R E Davis, M P Busch, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1997
Comparative rates of disease progression among persons infected with the same or different HIV-1 strains. The Transfusion Safety Study GroupE A Operskalski, M P Busch, J W Mosley, et al.
The Journal of Laboratory and Clinical Medicine|September 14, 2000
Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivityE Carrier, E Gilpin, T H Lee, et al.
Hepatology (Baltimore, Md.)|February 1, 1993
Analysis of hepatitis C virus RNA prevalence and surrogate markers of infection among seropositive voluntary blood donorsJ M Romeo, P P Ulrich, M P Busch, et al.
Transfusion|May 22, 2003
The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donationsB R Jackson, M P Busch, S L Stramer, et al.
Pageof 85